Array BioPharma and Genentech Form Another Cancer Collaboration

By Heather Cartwright

Pharma Deals Review: Vol 2011 Issue 8 (Table of Contents)

Published: 19 Aug-2011

DOI: 10.3833/pdr.v2011.i8.1526     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

Array BioPharma and Genentech have expanded their relationship in oncology by forming a second collaboration to develop both company’s small molecule checkpoint kinase 1 (ChK-1) programmes, which include Genentech’s Phase 1 GDC-0425 and Array’s preclinical-stage ARRY-575...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details